This methodological assessment used data from a randomized controlled noninferiority trial of patients with low-risk prostate cancer, conducted by NRG Oncology (ClinicalTrials.gov identifier: ...

Radiopharmaceutical therapy (RPT) combined with external beam radiotherapy (EBRT) is emerging as a powerful approach in prostate cancer treatment. Historically rooted in early 89Sr trials, this ...

Ultrasound-guided biopsies miss prostate cancers that are detected by the slightly more expensive and slightly more invasive 3D mapping biopsies. For example, in a 2006 study of 180 men diagnosed with ...

Care models for prostate cancer desperately need personalization, declared Shyam Natarajan, co-founder and CEO of Avenda Health. To address this issue, his Culver City, California-based company built ...

Genetic changes during the initiation and progression of prostate cancer have eluded scientists to date. Now for the first time researchers have identified a specific gene expression profile of ...

Avenda Health Inc. secured FDA 510(k) clearance for its Iquest platform, which uses artificial intelligence to map the location of a tumor within the prostate. The visualization created provides ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...